AZZ vs EW · P/E 14, rev $1.58B vs P/E 47, rev $1.39B
AZZ Incorporated (AZZ) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
AZZ Incorporated (AZZ) is a specialty business services company listed on NYSE.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AZZ revenue for 2025-02-28 was $1.58B. Net income was $128.8M. Revenue was up 2.6% from 2024-02-29 to 2025-02-28. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AZZ currently screens at market cap $4.56B and trailing P/E 14.5. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AZZ and EW stock pages for the full models.
Not investment advice.